Deepull Gains Strategic Backing as Mérieux Equity Partners Announces Fund Closing
Funding | Apr 29, 2025 | Merieux Equity Partners SAS
Mérieux Equity Partners, a private equity firm, has announced the successful first closing of its new Innovation fund, known as Mérieux Innovation 2 (MI2). In tandem with this inaugural closing, Mérieux has strategically invested in Deepull, a diagnostics company based in Spain. This move highlights Mérieux's commitment to advancing innovation in the diagnostics field. The investment in Deepull marks a key step in Mérieux's strategy to support companies that are pioneering novel solutions in diagnostics.
Sectors
- Private Equity
- Biotechnology & Diagnostics
Geography
- France – Mérieux Equity Partners is based in France, classifying this as a relevant geography.
- Spain – Deepull, the target company of the strategic investment, is based in Spain, making this a relevant geography classification.
Industry
- Private Equity – The article discusses the activities of Mérieux Equity Partners, which is a private equity firm focusing on investment and fund management.
- Biotechnology & Diagnostics – The article mentions Deepull, a company that operates in the diagnostic space, indicating involvement in the Biotechnology and Diagnostics industry.
Financials
- Not disclosed – The closing amount for the Mérieux Innovation 2 fund and the specific investment amount in Deepull have not been disclosed.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Mérieux Equity Partners SAS | PE Firm | Company | Mérieux Equity Partners is a private equity firm focusing on investments in healthcare and biotechnology. |
| Deepull | Investment Target | Company | Deepull is a diagnostics company based in Spain, targeted for investment by Mérieux Equity Partners. |